CN Patent
CN114644670A — 奥贝胆酸和对氨基苯甲酸的共晶及其制备方法
Assigned to Sichuan Hongyuan Pharmaceutical Co ltd · Expires 2022-06-21 · 4y expired
What this patent protects
本发明提供了一种奥贝胆酸和对氨基苯甲酸的共晶。本发明还涉及所述共晶的制备方法、其药物组合物及在制备治疗受试者中FXR介导的疾病或障碍的药物中的用途。
USPTO Abstract
本发明提供了一种奥贝胆酸和对氨基苯甲酸的共晶。本发明还涉及所述共晶的制备方法、其药物组合物及在制备治疗受试者中FXR介导的疾病或障碍的药物中的用途。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.